Of these, 4610/7889 were upregulated (58.44%, log2FC > 0) and 3279/7889 were downregulated (41.56%, log2FC < 0) in the AML-ASXL1 samples (Figure S1C). This evidence concerns the gene ASXL1 and acute myeloid leukemia.